DURECT Corp (DRRX.OQ)
DRRX.OQ on NASDAQ Stock Exchange Global Market
0.73USD
3:59pm EST
0.73USD
3:59pm EST
Change (% chg)
$-0.03 (-3.96%)
$-0.03 (-3.96%)
Prev Close
$0.76
$0.76
Open
$0.75
$0.75
Day's High
$0.76
$0.76
Day's Low
$0.70
$0.70
Volume
51,718
51,718
Avg. Vol
82,908
82,908
52-wk High
$2.55
$2.55
52-wk Low
$0.70
$0.70
About
Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)
Overall
| Beta: | 1.81 |
| Market Cap(Mil.): | $299.88 |
| Shares Outstanding(Mil.): | 147.00 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| DRRX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.71 | 34.39 |
| EPS (TTM): | -0.25 | -- | -- |
| ROI: | -109.40 | 9.01 | 14.96 |
| ROE: | -411.96 | 10.15 | 16.52 |
Estimates